BriaCell Therapeutics BCTX
NASDAQ BCTX
$3.63 +0.16 (+4.77%)
As of: Oct 21, 2026 · 3:02 PM EDT

BriaCell Therapeutics (BCTX) Revenue (2022)

Updated

Analysis

BriaCell Therapeutics (BCTX) Revenue (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,138.83 Bn 1,107.41 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 618.88 Bn 537.41 Bn 17.26 Bn 25.31 Bn
3 AbbVie 502.93 Bn 476.04 Bn 12.70 Bn 16.99 Bn
4 Merck 369.61 Bn 323.99 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.70 Bn 262.69 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.59 Bn 192.99 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.60 Bn 165.79 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.23 Bn 116.88 Bn 10.94 Bn 15.03 Bn
10 BriaCell Therapeutics 26.28 Mn -54.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2022 35,987.00
Jan 31, 2022 12,081.00
API Access

BriaCell Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=BCTX&period=max&api_key=YOUR_API_KEY